# Different Administration Regimens of CAZ-AVI in Combination With ATM for the Treatment of CR-GNB

> **NCT07478484** · PHASE4 · RECRUITING · sponsor: **Jing Zhou** · enrollment: 144 (estimated)

## Conditions studied

- Ceftazidime-avibactam
- Aztreonam
- Gram-negative Bacterial Infection
- Metallo-β-lactamase-producing
- Carbapenem-resistant

## Interventions

- **DRUG:** ceftazidime-avibactam combined with aztreonam

## Key facts

- **NCT ID:** NCT07478484
- **Lead sponsor:** Jing Zhou
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-31
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-01-31
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07478484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07478484, "Different Administration Regimens of CAZ-AVI in Combination With ATM for the Treatment of CR-GNB". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07478484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*